Bone / Cartilage · Bone / cartilage biology peptide · OSTP-019
[Tyr0] Calcitonin Gene Related Peptide, human
- Drug class
- Bone / cartilage biology peptide
- Status
- Research use only
- Catalog code
- OSTP-019
- Also known as
- OSTP-019
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What [Tyr0] Calcitonin Gene Related Peptide, human is studied for
- Osteoblast / osteoclast differentiation assays
- Chondrocyte and cartilage-explant remodeling studies
- Bone-resorption and mineralization models
- Biomaterial functionalization for orthopaedic scaffolds
Mechanism of action
[Tyr0] Calcitonin Gene Related Peptide, human sits within the Bone / Cartilage research class (CPC reference OSTP-019). These peptides interact with bone- and cartilage-relevant receptors and matrix proteins — including RANK/RANKL, PTH1R, integrins, and collagen-binding motifs — modulating osteoblast, osteoclast, and chondrocyte activity in cellular and organ-culture models. Investigators typically incorporate [Tyr0] Calcitonin Gene Related Peptide, human as a reference standard, tool ligand, or substrate in the assay contexts listed above. Commonly paired with ALP, TRAP, or Alizarin Red staining in cell-based readouts.
Frequently asked questions
What is [Tyr0] Calcitonin Gene Related Peptide, human?
[Tyr0] Calcitonin Gene Related Peptide, human (CPC catalog code OSTP-019) is a synthetic bone / cartilage biology peptide in the bone / cartilage category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
What is [Tyr0] Calcitonin Gene Related Peptide, human studied for?
Published and internal research programs use [Tyr0] Calcitonin Gene Related Peptide, human as a reference standard in bone / cartilage workflows — for example, osteoblast / osteoclast differentiation assays and chondrocyte and cartilage-explant remodeling studies. Human clinical evidence is not established.
Is [Tyr0] Calcitonin Gene Related Peptide, human FDA-approved for human use?
No. [Tyr0] Calcitonin Gene Related Peptide, human is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
How is [Tyr0] Calcitonin Gene Related Peptide, human typically used in the lab?
In a bone / cartilage workflow, [Tyr0] Calcitonin Gene Related Peptide, human is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Commonly paired with ALP, TRAP, or Alizarin Red staining in cell-based readouts.
How should [Tyr0] Calcitonin Gene Related Peptide, human be stored?
Store lyophilized at −20 °C. Reconstitute in sterile buffer immediately before use. Follow your institution's standard operating procedures for handling synthetic peptides.
Where does the [Tyr0] Calcitonin Gene Related Peptide, human product page point to?
This kindr reference page mirrors CPC Scientific's catalog metadata for OSTP-019. The upstream reference sheet — including sequence, purity, MW, and application notes where published — is linked from the buy panel. All orders placed on kindr Peptides ship internationally under research-use terms only.
What quality specifications apply to [Tyr0] Calcitonin Gene Related Peptide, human?
Research-grade peptides in the CPC catalog are synthesized by solid-phase peptide synthesis (SPPS), purified by preparative RP-HPLC, and characterized by analytical HPLC and mass spectrometry. Typical purity is ≥95%; certificate of analysis is available on request.
Related peptides in Bone / Cartilage
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- Is HRT safe?Journal
- When to start HRTJournal
- Menopause HRT serviceMedication
- Complete menopause guideJournal
![[Tyr0] Calcitonin Gene Related Peptide, human reference vial](/__l5e/assets-v1/83f67069-c2c2-4c3c-94fb-4667a75f74ae/peptide-vial-placeholder.jpg)